AGIO logo

Agios Pharmaceuticals, Inc.

AGIO

AGIO: Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

more

Show AGIO Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of AGIO by members of U.S. Congress

Politician Type Traded
Thomas Macarthur House / R Sale $1,001 - $15,000 May. 27, 2015
Thomas Macarthur House / R Purchase $1,001 - $15,000 Mar. 18, 2015
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by AGIO's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $40,000 Jul 14, 2023 Issue: None
  • $40,000 Apr 20, 2023 Issue: None
  • $40,000 Jan 14, 2023 Issue: None
  • $40,000 Oct 16, 2022 Issue: None
  • $40,000 Jul 15, 2022 Issue: None
  • $40,000 Apr 15, 2022 Issue: None
  • $40,000 Jan 15, 2022 Issue: Health Issues
  • $40,000 Oct 15, 2021 Issue: Health Issues
  • $40,000 Jul 17, 2021 Issue: None
  • $30,000 Apr 17, 2021 Issue: None
  • $20,000 Jan 11, 2012 Issue: Budget/Appropriations Defense Health Issues
  • $20,000 Oct 14, 2011 Issue: Defense Health Issues Budget/Appropriations
  • $20,000 Oct 12, 2010 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Defense
  • $30,000 Jul 16, 2010 Issue: Defense Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $30,000 Apr 18, 2010 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Defense
  • $30,000 Jan 06, 2010 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $30,000 Oct 13, 2009 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $30,000 Jul 19, 2009 Issue: Medical/Disease Research/Clinical Labs
U.S. Patents

New patents grants

  • Patent Title: Therapeutic compounds and compositions Jul. 18, 2023
  • Patent Title: Pyruvate kinase activators for use in treating blood disorders Feb. 28, 2023
  • Patent Title: Pyruvate kinase modulators and use thereof Oct. 11, 2022
  • Patent Title: Methods of treating brain tumors using combination therapy Oct. 04, 2022
  • Patent Title: Pyruvate kinase activators for use in treating blood disorders Jun. 21, 2022
  • Patent Title: Crystalline forms of n-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide Feb. 22, 2022
  • Patent Title: Methods of using pyruvate kinase activators Feb. 01, 2022
  • Patent Title: Pyruvate kinase activators for use in treating blood disorders Jun. 22, 2021
  • Patent Title: Therapeutically active compounds and their methods of use Jun. 01, 2021
  • Patent Title: Therapeutic compounds and compositions Apr. 27, 2021
  • Patent Title: Therapy for treating malignancies Apr. 20, 2021
  • Patent Title: Therapeutically active compounds and their methods of use Mar. 16, 2021
  • Patent Title: Combination therapy for treating malignancies Feb. 02, 2021
  • Patent Title: Inhibitors of cellular metabolic processes Oct. 13, 2020
  • Patent Title: Pharmaceutical compositions of therapeutically active compounds Oct. 13, 2020
  • Patent Title: Methods of treating brain tumors using combination therapy Sep. 22, 2020
  • Patent Title: Therapeutically active compounds and their methods of use Aug. 04, 2020
  • Patent Title: Therapeutically active compounds and their methods of use Jul. 21, 2020
  • Patent Title: Methods for diagnosing idh-mutant cell proliferation disorders Jul. 14, 2020
  • Patent Title: Therapeutically active compounds and their methods of use Jun. 23, 2020
  • Patent Title: Compounds and their methods of use Jun. 23, 2020
  • Patent Title: Combination therapy for treating malignancies May. 19, 2020
  • Patent Title: Therapeutically active compositions and their methods of use May. 05, 2020
  • Patent Title: Pharmaceutical compositions of therapeutically active compounds Oct. 22, 2019
  • Patent Title: Therapeutically active compounds and their methods of use Oct. 08, 2019
  • Patent Title: Glutaminase inhibitors and method of use Sep. 17, 2019
  • Patent Title: 2,4- or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer Aug. 13, 2019
  • Patent Title: Inhibitors of cellular metabolic processes Jun. 25, 2019
  • Patent Title: Therapeutically active compounds and their methods of use May. 21, 2019
  • Patent Title: Therapeutic compounds and compositions Feb. 12, 2019
  • Patent Title: Therapeutically active compounds and their methods of use Feb. 12, 2019
  • Patent Title: Methods of treatment of malignancies Jan. 29, 2019
  • Patent Title: Therapeutically active compounds and their methods of use Jan. 08, 2019
  • Patent Title: N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as idh2 mutants inhibitors for the treatment of cancer Oct. 30, 2018
  • Patent Title: Therapeutically active compounds and their methods of use Oct. 23, 2018
  • Patent Title: Methods of evaluating patients using e-cadherin or vimentin Oct. 16, 2018
  • Patent Title: Therapeutically active compounds and their methods of use Oct. 09, 2018
  • Patent Title: Compounds and their methods of use Oct. 02, 2018
  • Patent Title: Bicyclic pkm2 activators Oct. 02, 2018
  • Patent Title: Therapeutic compounds and compositions Jul. 24, 2018
  • Patent Title: Therapeutically active compounds and their methods of use Jul. 24, 2018
  • Patent Title: Therapeutically active compounds and their methods of use Jul. 10, 2018
  • Patent Title: Glutaminase inhibitors and method of use Jul. 03, 2018
  • Patent Title: Compounds and their methods of use Jun. 19, 2018
  • Patent Title: Method for treating cell proliferation related disorders May. 29, 2018
  • Patent Title: Pyruvate kinase activators for use in therapy May. 29, 2018
  • Patent Title: Pharmaceutical compositions of therapeutically active compounds May. 15, 2018
  • Patent Title: Therapeutic compositions and related methods of use Apr. 10, 2018
  • Patent Title: Therapeutically active compounds and their methods of use Feb. 13, 2018
  • Patent Title: Therapeutically active compositions and their methods of use Jan. 02, 2018
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of AGIO in WallStreetBets Daily Discussion

AGIO News

Recent insights relating to AGIO

CNBC Recommendations

Recent picks made for AGIO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AGIO

Corporate Flights

Flights by private jets registered to AGIO